loading

Amylyx Pharmaceuticals Inc Aktie (AMLX) Neueste Nachrichten

pulisher
Jun 18, 2025

Amylyx Pharmaceuticals (NASDAQ:AMLX) Coverage Initiated by Analysts at Citigroup - Defense World

Jun 18, 2025
pulisher
Jun 17, 2025

Citi initiates Amylyx stock with buy rating on promising pipeline By Investing.com - Investing.com South Africa

Jun 17, 2025
pulisher
Jun 17, 2025

Amylyx Pharmaceuticals, Inc. (AMLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jun 17, 2025
pulisher
Jun 17, 2025

Citi initiates Amylyx stock with buy rating on promising pipeline - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Amylyx Pharmaceuticals (AMLX): Citigroup Initiates Coverage with 'Buy' Rating | AMLX Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Amylyx initiated with a Buy at Citi - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Amylyx (AMLX) Gains Positive Outlook with New Analyst Coverage | AMLX Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 16, 2025

Diabetes Insipidus Market Statistics Expected to Experience - openPR.com

Jun 16, 2025
pulisher
Jun 15, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Amylyx Pharmaceuticals, Inc. (AMLX) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Jun 15, 2025
pulisher
Jun 14, 2025

Amylyx gets FDA fast track status for ALS treatment - MSN

Jun 14, 2025
pulisher
Jun 14, 2025

Amylyx Pharmaceuticals (NASDAQ:AMLX) Lowered to Sell Rating by Wall Street Zen - Defense World

Jun 14, 2025
pulisher
Jun 14, 2025

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Given Average Recommendation of “Buy” by Brokerages - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Amylyx Pharmaceuticals, Inc. (AMLX) Investors to Inquire about Securities Investigation - ACCESS Newswire

Jun 12, 2025
pulisher
Jun 11, 2025

# H.C. Wainwright reiterates Buy rating on AMYLYX stock ahead of trial - Investing.com India

Jun 11, 2025
pulisher
Jun 11, 2025

Optimistic Buy Rating for Amylyx Pharmaceuticals’ AMX0114 Based on Promising ALS Treatment Mechanism and Trial Insights - TipRanks

Jun 11, 2025
pulisher
Jun 10, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Investors to Reach Out - ACCESS Newswire

Jun 10, 2025
pulisher
Jun 10, 2025

AMX0114 receives FDA fast track status for the treatment of ALS - ALS News Today

Jun 10, 2025
pulisher
Jun 08, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Amylyx Pharmaceuticals, Inc. (AMLX) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Jun 08, 2025
pulisher
Jun 08, 2025

Wellington Management Group LLP Purchases New Stake in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Ameriprise Financial Inc. Purchases Shares of 50,428 Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Amylyx Pharmaceuticals Inc Holds Annual Stockholder Meeting - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

Corcept plots future for ALS drug that flunked Phase 2, citing survival analysis - Endpoints News

Jun 05, 2025
pulisher
Jun 04, 2025

DEADLINE ALERT: Bernstein Liebhard LLP Reminds Amylyx Pharmaceuticals, Inc. Investors of Upcoming Deadline - ACCESS Newswire

Jun 04, 2025
pulisher
Jun 04, 2025

FDA fast tracks Amylyx’s ALS drug candidate AMX0114 By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 03, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Amylyx Pharmaceuticals, Inc. (AMLX) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 03, 2025

Amylyx Pharmaceuticals Receives U.S. FDA Fast Track Designation for AMX0114 for the Treatment of Amyotrophic Lateral Sclerosis - BioSpace

Jun 03, 2025
pulisher
Jun 03, 2025

Amylyx Pharmaceuticals' Potential ALS Treatment Gets FDA Fast Track Designation - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Amylyx (AMLX) Gains FDA Fast Track Status for ALS Treatment | AM - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

FDA fast tracks Amylyx’s ALS drug candidate AMX0114 - Investing.com

Jun 03, 2025
pulisher
Jun 02, 2025

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Shares Purchased by Millennium Management LLC - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Shareholders to Connect - ACCESS Newswire

Jun 01, 2025
pulisher
Jun 01, 2025

Northern Trust Corp Purchases 11,214 Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Amylyx Pharmaceuticals (NASDAQ:AMLX) Now Covered by TD Cowen - Defense World

May 31, 2025
pulisher
May 31, 2025

TD Cowen starts Amylyx stock coverage with Buy rating - Investing.com Australia

May 31, 2025
pulisher
May 30, 2025

Amylyx (AMLX) Receives Buy Rating from TD Cowen on Avexitide Pot - GuruFocus

May 30, 2025
pulisher
May 30, 2025

TD Cowen starts Amylyx stock coverage with Buy rating By Investing.com - Investing.com Nigeria

May 30, 2025
pulisher
May 30, 2025

Amylyx (AMLX) Receives Buy Rating from TD Cowen on Avexitide Potential | AMLX Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Amylyx initiated with a Buy at TD Cowen - TipRanks

May 30, 2025
pulisher
May 29, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Investors to Connect - ACCESS Newswire

May 29, 2025
pulisher
May 29, 2025

2025-05-29 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Investors to Connect | NDAQ:AMLX | Press Release - Stockhouse

May 29, 2025
pulisher
May 28, 2025

Amyotrophic lateral Sclerosis Market 2025-2032: Top Trends & - openPR.com

May 28, 2025
pulisher
May 28, 2025

🌐 ALS Treatment Market to Hit $1.04 Billion by 2032 | Driven by New Drug Approvals & Asia-Pacific Expansion - openPR.com

May 28, 2025
pulisher
May 27, 2025

Man Group plc Trims Stock Position in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - Defense World

May 27, 2025
pulisher
May 25, 2025

Bank of America Corp DE Increases Stock Holdings in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - Defense World

May 25, 2025
pulisher
May 25, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Amylyx Pharmaceuticals, Inc. (AMLX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

May 25, 2025
pulisher
May 24, 2025

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Shares Sold by D. E. Shaw & Co. Inc. - Defense World

May 24, 2025
pulisher
May 22, 2025

Amylyx Pharmaceuticals, Inc. (AMLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

May 22, 2025
pulisher
May 21, 2025

Amylyx Pharmaceuticals to Participate in Upcoming June Investor Conferences - BioSpace

May 21, 2025
$20.42
price down icon 1.37%
$35.45
price up icon 0.65%
$21.06
price down icon 1.92%
$101.83
price down icon 0.41%
$105.86
price down icon 0.39%
biotechnology ONC
$244.00
price down icon 3.69%
Kapitalisierung:     |  Volumen (24h):